Needle-free subcutaneous sumatriptan: In the acute treatment of migraine attacks or cluster headache episodes

CNS Drugs

Volumn 25, Issue 11, 2011, Pages 983-994

  Frampton, James E ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

Adis Drug Profiles; Antimigraines; Cluster headache; Migraine; Subcutaneous; Sumatriptan

Indexed keywords

SUMATRIPTAN SUCCINATE; TRIPTAN DERIVATIVE;

APPLICATION SITE BLEEDING; APPLICATION SITE ERYTHEMA; APPLICATION SITE PAIN; APPLICATION SITE SWELLING; ARTICLE; CLUSTER HEADACHE; DIZZINESS; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG SELF ADMINISTRATION; DRUG TOLERABILITY; FLUSHING; HEAT SENSATION; HUMAN; MIGRAINE; MULTICENTER STUDY (TOPIC); MUSCLE WEAKNESS; NAUSEA; NECK PAIN; NEEDLE; PARESTHESIA; PATIENT SATISFACTION; PHARMACODYNAMICS; PHONOPHOBIA; PHOTOPHOBIA; PRESSURE SENSATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECOMMENDED DRUG DOSE; SIDE EFFECT; SINGLE DRUG DOSE; SKIN BRUISING; SKIN TINGLING; SYMPTOMATOLOGY; THORAX PAIN; TREATMENT OUTCOME; VERTIGO; VOMITING;

CLINICAL TRIALS, PHASE IV AS TOPIC; CLUSTER HEADACHE; DRUG DELIVERY SYSTEMS; HUMANS; INFUSIONS, SUBCUTANEOUS; MIGRAINE DISORDERS; NEEDLES; SEROTONIN 5-HT1 RECEPTOR AGONISTS; SUMATRIPTAN; TREATMENT OUTCOME; TRYPTAMINES;

EID: 80555139999     PISSN: 11727047     EISSN: 11791934     Source Type: Journal    
DOI: 10.2165/11208230-000000000-00000     Document Type: Article

References (37)

1. Lipton RB, Bigal ME. Migraine: epidemiology, impact, and risk factors for progression. Headache 2005 Apr; 45 Suppl. 1: S3-13 (Pubitemid 40532985)
2. Perry CM, Markham A. Sumatriptan: an updated review of its use in migraine. Drugs 1998 Jun; 55 (6): 889-922 (Pubitemid 28257001)
3. Stewart WF, Wood C, Reed ML, et al. Cumulative lifetime migraine incidence in women and men. Cephalalgia 2008 Nov; 28 (11): 1170-8
4. Stovner LJ, Zwart JA, Hagen K, et al. Epidemiology of headache in Europe. Eur J Neurol 2006 Apr; 13 (4): 333-45
5. Burton WN, Landy SH, Downs KE, et al. The impact of migraine and the effect ofmigraine treatment on workplace productivity in the United States and suggestions for future research. Mayo Clin Proc 2009 May; 84 (5): 436-45
6. Loder E. Triptan therapy in migraine. N Engl J Med 2010 Jul 1; 363 (1): 63-70
7. Ekbom K, Hardebo JE. Cluster headache: aetiology, diagnosis and management. Drugs 2002; 62 (1): 61-9 (Pubitemid 34169426)
8. Torelli P, Castellini P, Cucurachi L, et al. Cluster headache prevalence: methodological considerations. A review of the literature. Acta Biomed 2006 Apr; 77 (1): 4-9
9. Dowson AJ, Lipscombe S, Sender J, et al. New guidelines for the management of migraine in primary care. Curr Med Res Opin 2002; 18 (7): 414-39 (Pubitemid 35448539)
10. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 55 (6): 754-62
11. Evers S, Afra J, Frese A, et al. EFNS guideline on the drug treatment of migraine: revised report of an EFNS task force. Eur J Neurol 2009; 16 (9): 968-81
12. Bigal ME, Krymchantowski AV, Hargreaves R. The triptans. Expert Rev Neurother 2009 May; 9 (5): 649-59
13. Johnston MM, Rapoport AM. Triptans for the management of migraine. Drugs 2010 Aug; 70 (12): 1505-18
14. Moen MD, Keating GM. Sumatriptan fast-disintegrating/rapid-release tablets. Drugs 2006; 66 (6): 883-90 (Pubitemid 43765232)
15. Curran MP, Evans HC, Wagstaff AJ. Intranasal sumatriptan: in adolescents with migraine. CNS Drugs 2005; 19 (4): 335-43; discussion 345-6 (Pubitemid 40593604)
16. Ostrovsky G. Zelrix sumatriptan anti-migraine patch going to FDA for review [online]. Available from URL: http://medgadget.com [Accessed 2011 Sep 22]
17. Rapoport AM, Freitag F, Pearlman SH. Innovative delivery systems for migraine: the clinical utility of a transdermal patch for the acute treatment of migraine. CNS Drugs 2010; 24 (11): 929-40
18. Cady RK, Aurora SK, Brandes JL, et al. Satisfaction with and confidence in needle-free subcutaneous sumatriptan in patients currently treated with triptans. Headache 2011 Sep; 51 (8): 1202-11
19. Gruffydd-Jones K, Hood CA, Price DB. A within-patient comparison of subcutaneous and oral sumatriptan in the acute treatment of migraine in general practice. Cephalalgia 1997 Feb; 17 (1): 31-6 (Pubitemid 27101418)
20. Kaniecki RG. Mixing sumatriptan: a prospective study of stratified care using multiple formulations. Headache 2001 Oct; 41 (9): 862-6 (Pubitemid 33043149)
21. Silberstein SD. Migraine symptoms: results of a survey of self-reported migraineurs. Headache 1995; 35 (7): 387-96
22. Lipton RB, Stewart WF. Acute migraine therapy; do doctors understand what patients with migraine want from therapy? Headache 1999; 39 Suppl. 2: S20-6 (Pubitemid 30002025)
23. Freitag FG. Sumatriptan needle-free subcutaneous (Sumavel DosePro) approved for the acute treatment of migraine, with or without aura, and cluster headaches. Expert Rev Neurother 2011 Apr; 11 (4): 481-90
24. Rothrock JF, Morey V. 'Mixing triptans': patient satisfaction. Headache 2011; 51: 135-40
25. May A, Leone M, Afra J, et al. EFNS guidelines on the treatment of cluster headache and other trigeminalautonomic cephalalgias. Eur J Neurol 2006; 13: 1066-77 (Pubitemid 44434311)
26. Hamilton JG. Needle phobia: a neglected diagnosis. J Fam Pract 1995 Aug; 41 (2): 169-75
27. Brandes JL, Cady RK, Freitag FG, et al. Needle-free subcutaneous sumatriptan (Sumavel DosePro): bioequivalence and ease of use. Headache 2009 Nov; 49 (10): 1435-44
28. Zogenix Inc. Sumavel DosePro(sumatriptan injection) approved by FDA for acute migraine and cluster headache: first product featuring novel DosePro needle-free delivery system [media release]. 2009 Jul 16 [online]. Available from URL: http://www.zogenix.com [Accessed 2011 Sep 23]
29. Zogenix Inc, Desitin Pharmaceuticals GmbH. Zogenix and Desitin announce first European marketing approval for Sumavel DosePro[media release]. 2010 Dec 2 [online]. Available from URL: http://www.zogenix.com [Accessed 2011 Sep 23]
30. Sumavel DosePro(sumatriptan injection) for subcutaneous use. US prescribing information. San Diego (CA); Zogenix Inc. [online]. Available from URL: http://www.zogenix. com/downloads/SV0468.0611-SDP-PI.pdf [Accessed 2011 Sep 23]
31. Center for Drug Evaluation and Research. Application number 22-239: clinical pharmacology and biopharmaceutics review(s) [online]. Available from URL: http://www.accessdata.fda.gov/drugsatfda-docs/nda/2009/02223 9s000ClinPharmr.pdf [Accessed 2011 Sep 22]
32. Imitrex(sumatriptan succinate) injection. US prescribing information. Research Triangle Park (NC); GlaxoSmith-Kline [online]. Available from URL: http://us.gsk.com/products/assets/us-imitrex-injection.pdf [Accessed 2011 Sep 23]
33. Zogenix Inc. Evaluation of treatment satisfaction and preference for Sumavel DoseProin the treatment of migraine [ClinicalTrials.gov identifier NCT01016834]. US National Institutes of Health, ClinicalTrials.gov [online]. Available from URL: http://clinicaltrials.gov [Accessed 2011 Sep 22]
34. Rothrock JF, Cady RK, Aurora SK, et al. Needle-free subcutaneous sumatriptan for triptan users requiring a change in migraine therapy: efficacy and impact on patient-rated functionality, satisfaction, and confidence. Curr Med Res Opin 2011; 27 (11): 2185-91
35. Kimel M, Hsieh R, McCormack J, et al. Validation of the revised Patient Perception of Migraine Questionnaire (PPMQ-R): measuring satisfaction with acute migraine treatment in clinical trials. Cephalalgia 2008; 28 (5): 510-23 (Pubitemid 351502541)
36. Center for Drug Evaluation and Research. Application number 22-239: medical review(s) [online]. Available from URL: http://www.accessdata.fda.gov/ drugsatfda-docs/nda/2009/022239s000Medr.pdf [Accessed 2011 Sep 22]
37. Zogenix Inc. A study on the effects of repeat doses of Intraject-sumatriptan on local site signs [ClinicalTrials. gov identifier NCT00620425]. US National Institutes of Health, ClinicalTrials.gov [online]. Available from URL: http://clinicaltrials.gov [Accessed 2011 Jul 11]